熊去氧胆酸胶囊对黄疸型肝炎退黄的疗效观察
被引量:3
摘要
熊去氧胆酸胶囊对黄疸型肝炎退黄的疗效是为了提高治疗黄疸型肝炎,保肝消退黄疸(简称退黄)疗效,本院于2009年2月~2010年2月熊去氧胆酸胶囊(UDCA),治疗黄疸型肝炎50例,观察期降酶退黄,改善肝功能的疗效,保肝抗炎,退黄,取得了较满意的疗效,现报道如下。
出处
《中外医学研究》
2011年第24期22-23,共2页
CHINESE AND FOREIGN MEDICAL RESEARCH
参考文献28
-
1Jazrawi RP,De Caestecker JS,Gogginp M,et al.Kinetics of hepatic bile acid handing in cholestatic liver disease:effect of ursodeoxycholic acid.Gastroenterology,1994,106:134-142.
-
2Poupon RE,Chretien Y,Poupon R,et al.Serum bile acids in primary billiary cirrhosis:effect of ursodeoxycholic acid therapy.Hepatology,1993,17:599-604.
-
3Poupon RE,Balkau B,Eschwege E,et al.A multicenter,controlled trial of ursodiol for the treatment of primary billiary cirrhosis.UDCA-PBC study Group.N Engl J Med,1991,324:1548-1554.
-
4Beuers U,Spengler U,Kruis W,et al.Ursodeoxycholic acid for treatment of primary sclerosing cholangitis:a placebo-controlled trial.Hepatology,1992,16:707-714.
-
5Heathcote EJ,Cauch-Dudek K,Walker V,et al.The Canadian Multicenter Double-blind Randomized Controlled Trial of ursodeoxycholic acid in primary billiary cirrhosis.Hepatology,1994,19:1149-1156.
-
6Lindor KD.Ursodiol for primary sclerosing cholangitis.Mayo Primary Sclerosing Cholangitis-Ursodeoxycholic Acid study Group.N Engl J Med,1997,336:691-695.
-
7Medina JF,Martinez A,Vazquez JJ,et al.Decreased antion excganger immunoreactivity in the liver of patients with primary billarycirrhosis.Hepatology,1997,25:12-17.
-
8Fickert P,Zollner G,Fuchsbichler A,et al.Effects of ursodeoxycholic and cholic acid feeding on hepatocellular transporter expression in mouse liver.Gastroenterology,2001,121:170-183.
-
9Beuers U,Blizer M,Chittattu A,et al.Taurourodeoxycholic acid inserts the apical conjugate export pump,Mrp2,into canalicular membranes and stimulates organic antion secretion by protein kinase C-dependent mechanisms in cholestatic rat liver.Hepatology,2001,33:1206-1216.
-
10Kurz AK,Graf D,Schmitt M,et al.Tauroursodeoxycholate-induced choleresis involves p38(MAPK)activation andtranslocation of the bile salt expoetpump in rats.Gastroenterology,2001,121:407-19.
同被引文献23
-
1吕以培,冼苏,李舒敏,李媛,刘良华.糖尿病性肝病17例临床分析[J].广西医科大学学报,2005,22(2):300-301. 被引量:6
-
2Ohta Y,Kongo M,Kishikawa T. Effect of melatonin on changes in hepatic antioxidant enzyme activities in rats treated with alphanaphthylisothiocyanate[J].Journal of Pineal Research,2001.370-377.
-
3Park HJ,Oh JH,Park SM. Identification of biomarkers of chemically induced hepatocarcinogenesis in rasH2 mice by toxicogenomic analysis[J].Archives of Toxicology,2011.1627-1640.
-
4Sama C,Rusticali AG,Morselli-Labate AM. Effect of ursodeoxycholic acid on liver tests in chronic hepatitis:assessment of prognostic parameters[J].Clinical Drug Investigation,1997.192-198.
-
5Yoshizaki K. Pathogenic role of IL-6 combined with TNF-alpha or IL-1 in the induction of acute phase proteins SAA and CRP in chronic inflammatory diseases[J].Advances in Experimental Medicine and Biology,2011.141-150.
-
6Zhao L,Tang Y,You Z. Interleukin-17 contributes to the pathogenesis of autoimmune hepatitis through inducing hepatic interleukin-6 expression[J].PLoS One,2011.e18909.
-
7Faiola B,Peterson RA,Kimbrough CL. Acute ANIT toxicity in male IL-10 knockout and wild-type mice[J].Toxicologic Pathology,2010.745-755.
-
8Miller AM,Wang H,Bertola A. Inflammation-associated interleukin-6/signal transducer and activator of transcription 3 activation ameliorates alcoholic and nonalcoholic fatty liver diseases in interleukin-10-deficient mice[J].Hepatology,2011.846-856.
-
9Copaci I,Micu L,Iliescu L. New therapeutical indications of ursodeoxycholic acid[J].Romanian Journal of Gastroenterology,2005.259-266.
-
10张学凤,郭辉.熊去氧胆酸胶囊治疗老年戊型淤胆型肝炎的临床观察[J].中国老年保健医学,2008,6(1):62-62. 被引量:15
引证文献3
-
1李绍佐,丁贤君,徐方明,王晔恺,钱立勇,曾芳,李世波.熊去氧胆酸对急性肝损伤大鼠细胞因子和肝脏炎症的影响[J].中华临床感染病杂志,2013,6(3):181-183. 被引量:2
-
2顾生旺,蒋兆荣,刘欢,常成.国产熊去氧胆酸胶囊致严重过敏性荨麻疹1例[J].肝脏,2013,18(10):723-723. 被引量:3
-
3高羽,梁华,龙恩武,李根.1例糖尿病合并甲状腺功能减退并发肝功能异常患者的药学监护[J].中国药业,2017,26(1):82-85. 被引量:2
二级引证文献7
-
1薛栋.腺苷蛋氨酸与多烯磷脂酰胆碱治疗酒精性肝硬化的临床效果对比[J].世界最新医学信息文摘,2019,0(83):137-137.
-
2赵强,陶艳艳,刘成海.丹参多酚酸盐注射液在肝病治疗中的应用[J].中华中医药学刊,2015,33(8):1929-1932. 被引量:3
-
3薛倩,彭涛,王晶桐.熊去氧胆酸胶囊致药物性肝损害1例[J].中华肝脏病杂志,2015,23(9):714-715. 被引量:3
-
4高明,任章平.熊去氧胆酸联合护肝药物对婴儿肝炎综合征生化指标的影响[J].肝脏,2016,21(2):123-125. 被引量:11
-
5王勇.五味降酶丸联合熊去氧胆酸治疗慢性肝炎的疗效观察[J].中国现代药物应用,2016,10(10):253-254. 被引量:5
-
6史秀梅,胡永领,谢士宁,赵艳艳.临床药学监护对肝功能损害患者疗效及用药安全性的影响[J].贵州医药,2019,43(7):1160-1161. 被引量:10
-
7曾小兰.注射用奥美拉唑致严重过敏性休克一例[J].临床医药文献电子杂志,2020,7(51):172-172. 被引量:1
-
1许正锯,黄以群,王崇国,李树清.大黄治疗伴高胆红素血症病毒性肝炎的疗效观察[J].重庆医学,2004,33(1):105-106. 被引量:5
-
2黄世翠,廖勇,王武兴.甘利欣联合干扰素治疗慢性乙型肝炎的疗效观察[J].实用医技杂志,2007,14(7).
-
3陈小聪,邓鑫,李椿莹,覃晓雾,莫荔荔.中药结合抗病毒治疗慢性乙型肝炎的研究近况[J].大众科技,2016,18(2):109-110. 被引量:2
-
4俞广芹.苦黄注射液治疗慢性乙型肝炎的疗效观察[J].实用心脑肺血管病杂志,2010,18(12):1793-1794. 被引量:2
-
5梅建华,陈百春.苦参碱联用还原型谷胱甘肽治疗慢性乙型肝炎[J].现代中西医结合杂志,2007,16(8):1042-1043.
-
6王晓丽,卫志干.苦参碱注射液治疗慢性乙型肝炎28例[J].实用医技杂志,2006,13(22):3989-3989.
-
7沈桂堂.小剂量肝素与拉米夫定联合治疗肝炎后肝硬化33例[J].世界感染杂志,2007,7(6):494-495.
-
8郭文征,康庄.老药新用治疗病毒性肝炎[J].国际医药卫生导报,2005,11(12):87-88. 被引量:3
-
9陈波,哈忠英.血塞通治疗病毒性肝炎高胆红素血症[J].河北医学,2001,7(12):1101-1102. 被引量:8
-
10洪玉兰,魏运辉.苦参碱治疗慢性乙型肝炎的临床观察[J].现代诊断与治疗,2005,16(6):341-342.